SV1997000081A - Intermediantes y procedimiento para obtener olanzapina ref. x- 10986t - Google Patents

Intermediantes y procedimiento para obtener olanzapina ref. x- 10986t

Info

Publication number
SV1997000081A
SV1997000081A SV1997000081A SV1997000081A SV1997000081A SV 1997000081 A SV1997000081 A SV 1997000081A SV 1997000081 A SV1997000081 A SV 1997000081A SV 1997000081 A SV1997000081 A SV 1997000081A SV 1997000081 A SV1997000081 A SV 1997000081A
Authority
SV
El Salvador
Prior art keywords
olanzapina
ref
intermediates
procedure
obtaining
Prior art date
Application number
SV1997000081A
Other languages
English (en)
Inventor
Charles Arthur Bunnell
Samuel Dean Larsen
John Richard Nichols
Susan Marie Reutzel
Gregogy Alan Stephenson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21832120&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SV1997000081(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of SV1997000081A publication Critical patent/SV1997000081A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LA PRESENTE INVENCION SELECCIONA CON UN PROCESO PARA PREPARAR 2-METIL-4-(4-METIL-1-PIPERACINILO)-10H-TIENO[1,5]BENZODIACEPINA (AL CUAL SE HARA REFERENCIA EN LA MEMORIA COMO OLANZAPINA)
SV1997000081A 1996-09-23 1997-09-22 Intermediantes y procedimiento para obtener olanzapina ref. x- 10986t SV1997000081A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2648796P 1996-09-23 1996-09-23

Publications (1)

Publication Number Publication Date
SV1997000081A true SV1997000081A (es) 1999-01-14

Family

ID=21832120

Family Applications (1)

Application Number Title Priority Date Filing Date
SV1997000081A SV1997000081A (es) 1996-09-23 1997-09-22 Intermediantes y procedimiento para obtener olanzapina ref. x- 10986t

Country Status (36)

Country Link
US (1) US6020487A (es)
EP (1) EP0831098B1 (es)
JP (2) JP2001500877A (es)
KR (1) KR100560015B1 (es)
CN (1) CN1122036C (es)
AR (1) AR013838A1 (es)
AT (1) ATE209208T1 (es)
AU (1) AU719441B2 (es)
BR (1) BR9712100A (es)
CA (1) CA2265712C (es)
CO (1) CO4910140A1 (es)
CZ (1) CZ299248B6 (es)
DE (1) DE69708428T2 (es)
DK (1) DK0831098T3 (es)
EA (1) EA001642B1 (es)
EG (1) EG23861A (es)
ES (1) ES2166051T3 (es)
HK (1) HK1009807A1 (es)
HU (1) HU226484B1 (es)
ID (1) ID27275A (es)
IL (1) IL128962A (es)
IN (1) IN187156B (es)
MY (1) MY125565A (es)
NO (1) NO323980B1 (es)
NZ (1) NZ334448A (es)
PE (1) PE110398A1 (es)
PL (3) PL196069B1 (es)
PT (1) PT831098E (es)
RS (1) RS49598B (es)
SI (1) SI0831098T1 (es)
SV (1) SV1997000081A (es)
TR (1) TR199900640T2 (es)
TW (1) TW470746B (es)
UA (1) UA59371C2 (es)
WO (1) WO1998012199A1 (es)
ZA (1) ZA978515B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0114031A (pt) * 2000-08-31 2003-09-09 Reddy S Lab Ltd Processo para a preparação de hidratos de olanzapina e sua conversão em formas cristalinas de olanzapina
US6740753B2 (en) 2001-01-04 2004-05-25 Geneva Pharmaceuticals, Inc. Olanzapine crystal modification
WO2003037903A1 (en) * 2001-10-29 2003-05-08 Dr. Reddy's Laboratories Ltd. Olanzapine dihydrate-ii a process for its preparation and use thereof
CA2471341C (en) 2001-12-24 2012-01-24 Sun Pharmaceutical Industries Limited Crystalline form i of 2-methyl-4-(4-methyl-1-piperazinyl) 10h thieno [2,3-b][1,5]benzodiazepine
AU2003243153A1 (en) * 2002-04-23 2003-11-10 Dr. Reddy's Laboratories Limited Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof
WO2003101997A1 (en) * 2002-05-31 2003-12-11 Geneva Pharmaceuticals, Inc. Process of preparation of olanzapine form i
SI21270A (sl) 2002-07-15 2004-02-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Kristalne oblike olanzapina in postopki za njihovo pripravo
WO2004058773A1 (en) * 2002-12-24 2004-07-15 Teva Pharmaceutical Industries Ltd. Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
EP1684734A2 (en) * 2003-11-18 2006-08-02 3M Innovative Properties Company Olanzapine containing transdermal drug delivery compositions
DE602004014264D1 (de) * 2003-12-22 2008-07-17 Teva Pharma Verfahren zur herstellung von olanzapin
WO2005070938A1 (en) 2004-01-27 2005-08-04 Synthon B.V. Stable salts of olanzapine
EP1716154A1 (en) * 2004-02-19 2006-11-02 Neuland Laboratories Ltd Process for the preparation of olanzapine form 1 useful as antipsychotic drug
US20080009481A1 (en) * 2004-07-14 2008-01-10 Shasun Chemicals And Drugs Limited Process For Making Form I Of Olanzapine
ES2253091B1 (es) 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
US7829700B2 (en) 2004-09-06 2010-11-09 Shasun Chemicals And Drugs Limited Process for preparation of a pharmaceutically pure polymorphic form I of Olanzapine
US7910577B2 (en) * 2004-11-16 2011-03-22 Elan Pharma International Limited Injectable nanoparticulate olanzapine formulations
US7834176B2 (en) 2006-01-26 2010-11-16 Sandoz Ag Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E
CA2591644A1 (en) * 2007-06-14 2008-12-14 Apotex Pharmachem Inc. Novel processes to form-i of olanzapine
EP2486913A1 (en) 2011-02-14 2012-08-15 Labtec GmbH Rapidly disintegrating oral film formulation for Olanzapin
JP6008734B2 (ja) * 2012-12-20 2016-10-19 株式会社トクヤマ オランザピンｉｉ型結晶の製造方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302716A (en) * 1986-01-16 1994-04-12 Schering Corporation Fused benzazepines
CA2002596A1 (en) * 1988-11-14 1990-05-14 Thomas M. Eckrich Hydrates of b-lactam antibiotic
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
NZ247703A (en) * 1992-05-29 1995-07-26 Lilly Industries Ltd Thienobenzdiazepine derivatives and medicaments thereof
US5550231A (en) * 1993-06-15 1996-08-27 Eli Lilly And Company Loracarbef hydrochloride C1-C3 alcohol solvates and uses thereof
US5602124A (en) * 1994-12-12 1997-02-11 Allelix Biopharmaceuticals, Inc. 5-HT2 receptor ligands
US5631250A (en) * 1995-03-24 1997-05-20 Eli Lilly And Company Process and solvate of 2-methyl-thieno-benzodiazepine
US5637584A (en) * 1995-03-24 1997-06-10 Eli Lilly And Company Solvate of olanzapine
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
EG24221A (en) * 1995-03-24 2008-11-10 Lilly Co Eli Process for preparing olanzapine
AU720366B2 (en) * 1996-09-23 2000-06-01 Eli Lilly And Company Olanzapine dihydrate D

Also Published As

Publication number Publication date
NO991382D0 (no) 1999-03-22
EA199900326A1 (ru) 1999-08-26
DE69708428T2 (de) 2002-07-04
PE110398A1 (es) 1999-01-14
EP0831098A2 (en) 1998-03-25
EG23861A (en) 2007-11-18
NO323980B1 (no) 2007-07-30
NO991382L (no) 1999-03-22
AU4484197A (en) 1998-04-14
PT831098E (pt) 2002-04-29
AU719441B2 (en) 2000-05-11
SI0831098T1 (en) 2002-04-30
ID27275A (id) 2001-03-22
DK0831098T3 (da) 2002-05-21
YU15599A (sh) 2001-12-26
TR199900640T2 (xx) 1999-06-21
IL128962A (en) 2003-01-12
PL332482A1 (en) 1999-09-13
PL196069B1 (pl) 2007-12-31
DE69708428D1 (de) 2002-01-03
CN1122036C (zh) 2003-09-24
EP0831098A3 (en) 1998-04-29
JP2009242407A (ja) 2009-10-22
PL196068B1 (pl) 2007-12-31
EP0831098B1 (en) 2001-11-21
MY125565A (en) 2006-08-30
PL194565B1 (pl) 2007-06-29
TW470746B (en) 2002-01-01
IL128962A0 (en) 2000-02-17
RS49598B (sr) 2007-06-04
IN187156B (es) 2002-02-16
NZ334448A (en) 2000-08-25
WO1998012199A1 (en) 1998-03-26
HK1009807A1 (en) 1999-06-11
ATE209208T1 (de) 2001-12-15
CA2265712A1 (en) 1998-03-26
JP2001500877A (ja) 2001-01-23
ZA978515B (en) 1999-03-23
HUP0000066A2 (hu) 2000-06-28
KR20000048520A (ko) 2000-07-25
CA2265712C (en) 2006-10-31
UA59371C2 (uk) 2003-09-15
HUP0000066A3 (en) 2000-11-28
AR013838A1 (es) 2001-01-31
CZ99099A3 (cs) 1999-11-17
HU226484B1 (en) 2009-03-02
EA001642B1 (ru) 2001-06-25
CO4910140A1 (es) 2000-04-24
ES2166051T3 (es) 2002-04-01
KR100560015B1 (ko) 2006-03-15
BR9712100A (pt) 1999-08-31
US6020487A (en) 2000-02-01
CN1234802A (zh) 1999-11-10
CZ299248B6 (cs) 2008-05-28

Similar Documents

Publication Publication Date Title
SV1997000081A (es) Intermediantes y procedimiento para obtener olanzapina ref. x- 10986t
ID18745A (id) Proses pembuatan sildenafil
BR9715215B1 (pt) tampão expansìvel lateralmente.
ATE245183T1 (de) Alternativer brennstoff
IT1296601B1 (it) Cellula fotoelettrica ad amplificazione stabilizzata.
DE69701272D1 (de) Kraftstoffkappe
DE69900738D1 (de) Kraftstoff-servicer
CA96914S (en) Electric par lamp
DK0829205T3 (da) Krydderiproduktion
ID21557A (id) Proses untuk pengkodean dengan daerah informasi
DE59705072D1 (de) Glühstiftkerze
NO981818D0 (no) FremgangsmÕte for Õ mobilisere hematopoetiske stamceller
ID16912A (id) Proses untuk pembuatan aldehida.
BR9711165B1 (pt) mÉtodo para imortalizar cÉlulas.
NL1002451A1 (nl) Sluitdop.
ID25511A (id) Proses dihidrogenasi dinitril
ID16207A (id) Proses untuk memproduksi 2,6-dimetilnaftalena dengan kemurnian tinggi
ZA996701B (en) Database query technique.
AU129320S (en) Stamper with cap
ID16702A (id) Penjilid berbentuk cincin
IT1280177B1 (it) Portalampada anti-infortunio
ID17623A (id) Proses pembuatan 1,2-dikloroetana dengan oksiklorinasi
ES1034537Y (es) Base de asiento.
ES1036819Y (es) Arrimadero de zocalo.
ES1029436Y (es) Pieza practicable con zocalo desmontable.

Legal Events

Date Code Title Description
FC Refusal
FD Lapse
FD Lapse